Lufax General Manager Dongqi Chen Resigns
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy LU?
Source: PRnewswire
- Executive Change: Dongqi Chen, General Manager of Lufax, has resigned effective March 31, 2026, due to personal work arrangements, which may impact the company's strategic direction and management stability.
- Acknowledgment of Contributions: The company expressed appreciation for Chen's significant contributions during his tenure, highlighting the importance of its executive team and recognition of leadership capabilities.
- Financing Product Focus: Lufax specializes in providing financing products for small business owners in China and has established partnerships with 85 financial institutions, enhancing its competitive position in the market.
- Long-term Partnerships: Many of Lufax's partners have collaborated for over three years, indicating the company's credibility and stability in the industry, which supports ongoing business development.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Lufax Securities Class Action Notice Issued
- Class Action Initiation: Rosen Law Firm has issued a reminder to investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they may be entitled to compensation without any out-of-pocket fees, highlighting the necessity of investor rights protection.
- Lawsuit Details Revealed: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in investor losses once the true information was disclosed, indicating significant governance deficiencies within the company.
- Law Firm Background: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, showcasing its expertise and successful track record, which enhances investor confidence in their representation.
- Investor Action Recommendations: Investors are encouraged to contact the law firm via the provided link or phone number to join the lawsuit, emphasizing the importance of selecting qualified legal counsel to effectively protect their rights in legal matters.
See More
Lufax Faces Class Action Lawsuit from Investors Over Securities Violations
- Class Action Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced a class action lawsuit against Lufax and certain officers, aiming to recover damages for investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, highlighting significant investor concerns regarding the company's financial transparency.
- Allegations Overview: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in materially false and misleading statements about the company's business, operations, and prospects, which could lead to substantial financial losses for investors.
- Investor Rights Protection: Investors have until May 20, 2026, to apply to be appointed as lead plaintiff in the case, indicating a strong commitment from the legal team to protect investor rights while also reflecting skepticism about the company's governance structure.
- Legal Team Credentials: Founded in 1888, Wolf Haldenstein Adler Freeman & Herz LLP boasts over 125 years of expertise in securities litigation, dedicated to pursuing justice for investors harmed by misrepresentations, underscoring its authority in the legal field.
See More
Faruqi & Faruqi Investigates Lufax Securities Litigation
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly encouraging investors who purchased securities between April 7, 2023, and January 26, 2025, to seek lead plaintiff status by the May 20, 2026 deadline.
- Allegations of Financial Misstatements: The lawsuit alleges that Lufax and its executives violated federal securities laws by failing to disclose inadequate internal controls and materially misstated financial results, which misled investors about the company's business and prospects, resulting in financial losses.
- Stock Price Impact: On January 27, 2025, Lufax disclosed a proposal to remove its auditors and a potential delay in its 2024 annual report, causing its American Depositary Shares (ADS) to drop by $0.40, or 13.8%, to close at $2.49, reflecting market concerns over corporate governance.
- Investor Rights Advocacy: Faruqi & Faruqi encourages anyone with information regarding Lufax's conduct, including whistleblowers and former employees, to contact the firm to provide legal support for affected investors, ensuring their rights are protected.
See More
Notice of Lufax Securities Class Action
- Class Action Timeline: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they must apply to be lead plaintiffs by May 20, 2026, to protect their rights in the class action lawsuit.
- Lawsuit Background: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the true information was revealed, which could negatively impact the company's reputation and future financing capabilities.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, demonstrating its expertise and success rate in this field, making it a preferable choice for investors seeking representation.
- Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, ensuring they select qualified legal counsel to maximize their chances of recovery and avoid inexperienced intermediary firms.
See More
Class Action Lawsuit Filed Against Lufax Holdings
- Class Action Initiation: Rosen Law Firm has filed a class action lawsuit against Lufax Holding Ltd (NYSE: LU) for securities purchasers between April 7, 2023, and January 26, 2025, indicating significant legal risks for the company as it seeks to compensate investors.
- Legal Procedure Requirements: Investors wishing to serve as lead plaintiffs must file with the court by May 20, 2026, highlighting the urgency of the case and its potential impact on investor recovery.
- Internal Control Deficiencies: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, leading to investor losses when the true information was revealed, reflecting weaknesses in the company's governance structure.
- Law Firm Credentials: Rosen Law Firm is renowned for its successful track record in securities class actions, having achieved the largest settlement against a Chinese company, demonstrating its expertise and influence in handling similar cases.
See More
Multiple Companies Face Class Action Lawsuits
- Lufax Lawsuit Overview: Lufax Holding Ltd. is facing a class action lawsuit for failing to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026, potentially impacting the company's reputation and stock price.
- Atara Biotherapeutics Issues: Atara Biotherapeutics, Inc. is under scrutiny for not disclosing manufacturing problems and clinical trial risks from May 20, 2024, to January 9, 2026, leading to investor misjudgment regarding its FDA approval prospects, with a lead plaintiff deadline of May 22, 2026, which could negatively affect future financing and market confidence.
- Coty Performance Decline: Coty Inc. faces a class action lawsuit due to underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026, likely putting pressure on the company's stock price and investor confidence.
- Super Micro Compliance Risks: Super Micro Computer, Inc. is involved in a class action lawsuit for failing to comply with U.S. export control laws from April 30, 2024, to March 12, 2026, with a lead plaintiff deadline of May 26, 2026, which may significantly impact the company's future compliance costs and market image.
See More
Lufax Securities Class Action Notice Issued
- Class Action Initiation: Rosen Law Firm has issued a reminder to investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they may be entitled to compensation without any out-of-pocket fees, highlighting the necessity of investor rights protection.
- Lawsuit Details Revealed: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in investor losses once the true information was disclosed, indicating significant governance deficiencies within the company.
- Law Firm Background: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, showcasing its expertise and successful track record, which enhances investor confidence in their representation.
- Investor Action Recommendations: Investors are encouraged to contact the law firm via the provided link or phone number to join the lawsuit, emphasizing the importance of selecting qualified legal counsel to effectively protect their rights in legal matters.
See More
Lufax Faces Class Action Lawsuit from Investors Over Securities Violations
- Class Action Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced a class action lawsuit against Lufax and certain officers, aiming to recover damages for investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, highlighting significant investor concerns regarding the company's financial transparency.
- Allegations Overview: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in materially false and misleading statements about the company's business, operations, and prospects, which could lead to substantial financial losses for investors.
- Investor Rights Protection: Investors have until May 20, 2026, to apply to be appointed as lead plaintiff in the case, indicating a strong commitment from the legal team to protect investor rights while also reflecting skepticism about the company's governance structure.
- Legal Team Credentials: Founded in 1888, Wolf Haldenstein Adler Freeman & Herz LLP boasts over 125 years of expertise in securities litigation, dedicated to pursuing justice for investors harmed by misrepresentations, underscoring its authority in the legal field.
See More
Faruqi & Faruqi Investigates Lufax Securities Litigation
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly encouraging investors who purchased securities between April 7, 2023, and January 26, 2025, to seek lead plaintiff status by the May 20, 2026 deadline.
- Allegations of Financial Misstatements: The lawsuit alleges that Lufax and its executives violated federal securities laws by failing to disclose inadequate internal controls and materially misstated financial results, which misled investors about the company's business and prospects, resulting in financial losses.
- Stock Price Impact: On January 27, 2025, Lufax disclosed a proposal to remove its auditors and a potential delay in its 2024 annual report, causing its American Depositary Shares (ADS) to drop by $0.40, or 13.8%, to close at $2.49, reflecting market concerns over corporate governance.
- Investor Rights Advocacy: Faruqi & Faruqi encourages anyone with information regarding Lufax's conduct, including whistleblowers and former employees, to contact the firm to provide legal support for affected investors, ensuring their rights are protected.
See More
Notice of Lufax Securities Class Action
- Class Action Timeline: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they must apply to be lead plaintiffs by May 20, 2026, to protect their rights in the class action lawsuit.
- Lawsuit Background: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the true information was revealed, which could negatively impact the company's reputation and future financing capabilities.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, demonstrating its expertise and success rate in this field, making it a preferable choice for investors seeking representation.
- Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, ensuring they select qualified legal counsel to maximize their chances of recovery and avoid inexperienced intermediary firms.
See More
Class Action Lawsuit Filed Against Lufax Holdings
- Class Action Initiation: Rosen Law Firm has filed a class action lawsuit against Lufax Holding Ltd (NYSE: LU) for securities purchasers between April 7, 2023, and January 26, 2025, indicating significant legal risks for the company as it seeks to compensate investors.
- Legal Procedure Requirements: Investors wishing to serve as lead plaintiffs must file with the court by May 20, 2026, highlighting the urgency of the case and its potential impact on investor recovery.
- Internal Control Deficiencies: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, leading to investor losses when the true information was revealed, reflecting weaknesses in the company's governance structure.
- Law Firm Credentials: Rosen Law Firm is renowned for its successful track record in securities class actions, having achieved the largest settlement against a Chinese company, demonstrating its expertise and influence in handling similar cases.
See More
Multiple Companies Face Class Action Lawsuits
- Lufax Lawsuit Overview: Lufax Holding Ltd. is facing a class action lawsuit for failing to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026, potentially impacting the company's reputation and stock price.
- Atara Biotherapeutics Issues: Atara Biotherapeutics, Inc. is under scrutiny for not disclosing manufacturing problems and clinical trial risks from May 20, 2024, to January 9, 2026, leading to investor misjudgment regarding its FDA approval prospects, with a lead plaintiff deadline of May 22, 2026, which could negatively affect future financing and market confidence.
- Coty Performance Decline: Coty Inc. faces a class action lawsuit due to underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026, likely putting pressure on the company's stock price and investor confidence.
- Super Micro Compliance Risks: Super Micro Computer, Inc. is involved in a class action lawsuit for failing to comply with U.S. export control laws from April 30, 2024, to March 12, 2026, with a lead plaintiff deadline of May 26, 2026, which may significantly impact the company's future compliance costs and market image.
See More
